| # | % | |||||
|---|---|---|---|---|---|---|
| 51 | GW PHARMACEUTICALS PLC | 18,000 | 1,648,000 | 0.70% | Call | |
| 52 | ATRICURE INC | 110,098 | 1,556,000 | 0.66% | ||
| 53 | INVACARE CORP COM | 125,000 | 1,517,000 | 0.64% | Call | |
| 54 | VIVEVE MED INC COM NEW | 368,919 | 1,513,000 | 0.64% | ||
| 55 | NUVASIVE INC | 25,000 | 1,493,000 | 0.63% | ||
| 56 | FLEX PHARMA INC COM | 142,000 | 1,450,000 | 0.62% | ||
| 57 | SYNERGY PHARMACEUTICALS DEL | 350,000 | 1,330,000 | 0.57% | ||
| 58 | Intersect ENT Inc | 100,000 | 1,293,000 | 0.55% | Call | |
| 59 | OPHTHOTECH CORP | 25,000 | 1,276,000 | 0.54% | Call | |
| 60 | WRIGHT MED GROUP N V | 586,936 | 740,000 | 0.31% | ||
| 61 | ALLIQUA BIOMEDICAL INC | 583,026 | 653,000 | 0.28% | ||
| 62 | FOAMIX PHARMACEUTICALS LTD | 102,000 | 648,000 | 0.28% | ||
| 63 | TONIX PHARMACEUTICALS HOLDING | 284,877 | 567,000 | 0.24% | ||
| 64 | INOTEK PHARMACEUTICALS CORP | 75,000 | 558,000 | 0.24% | ||
| 65 | FIVE PRIME THERAPEUTICS INC | 13,250 | 548,000 | 0.23% | ||
| 66 | ZOGENIX INC | 58,750 | 473,000 | 0.20% | ||
| 67 | Aldeyra Therapeutics Inc | 77,500 | 441,000 | 0.19% | ||
| 68 | ADAMIS PHARMACEUTICALS CORP | 155,500 | 435,000 | 0.18% | ||
| 69 | NEURODERM LTD | 24,683 | 401,000 | 0.17% | ||
| 70 | IMMUNOMEDICS INCORPORATED | 116,743 | 271,000 | 0.12% | ||
| 71 | OCERA THERAPEUTICS INC | 131,000 | 249,000 | 0.11% | ||
| 72 | ADMA BIOLOGICS, INC. | 36,500 | 217,000 | 0.09% | ||
| 73 | NEOVASC INC | 262,060 | 135,000 | 0.06% | ||
| 74 | STEADYMED LTD | 28,758 | 94,000 | 0.04% |
Portfolio data is normalized using SEC Form 13F filings, including the Original 13F-HR (0001493152-16-012350, filed 2016.08.15).
From 2023-01-03 onward, the SEC requires values to be reported in nearest dollars. Earlier filings reported values in thousands; therefore, positions shown as $0 in older filings may represent actual values between $0–$999.
